Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Another top-tier pharma puts APAS under the microscope

Clever Culture Systems
3:27pm
July 18, 2025
CC5 has announced global pharmaceutical heavyweight Novo Nordisk has placed an order for an APAS Independence system to be placed at its center of excellence central site in Denmark. The placement is intended for a comprehensive evaluation to determine its appropriateness for implementation throughout Novo's global manufacturing network for pharmaceutical environmental monitoring i.e. ensuring its 16 sterile manufacturing and fill-finish facilities remain free from contamination. The sale represents CC5’s fifth engagement with a leading pharma manufacturer, with units either installed or under evaluation at AstraZeneca, Bristol Myers Squibb, Thermo Fisher, a major multinational (name undisclosed), and now, Novo Nordisk.

Model update

Catalyst Metals
3:27pm
July 17, 2025
Ahead of the June quarter results we update our model to account for the recent Old Highway acquisition as well as adjustments to quarterly and FY26 forecasts. With the majority of ASX gold producers reporting unit costs to the upper end of our forecasts, we adjust our cost estimates to reflect the broader upward trend across the gold space. We upgrade CYL to a BUY recommendation (previously ACCUMULATE). Our target price moves to A$6.93ps (from A$7.15ps) as a function of unit cost adjustments.

A solid innings

Car Group
3:27pm
July 17, 2025
CAR has announced that current CEO and MD Cameron McIntrye will be stepping down from his leadership role that he held for over 9 years. Current CFO William Elliott will take over as CEO/MD effective 15 August 2025. Concurrently, CAR has pre-released some key unaudited FY25 result estimates. Broadly, FY25 revenue (midpoint A$1,144m), Adj EBITDA (midpoint A$640m) and Adj NPAT (midpoint A$378m) is per MorgansE and consensus expectations. We make only marginal changes to our estimates over the forecast period, largely related to released result estimates. Whilst brief commentary on the start to FY26 was positive, we await further detail at the FY25 result due out on 11 August. Our price target (A$40.80) and Accumulate recommendation remain unchanged at this juncture.

Cashflow stands out again, AISC trending higher

Evolution Mining
3:27pm
July 16, 2025
FY25 delivered – production, costs and capex met guidance with strong cash flow enabling further balance sheet deleveraging and early debt repayment. FY26 AISC to increase +14% on inflationary pressures and non-cash items. Solid EBITDA margins and continued deleveraging provide share price support, but EVN appears fully valued and we suggest taking profits. Move to TRIM.

Everyone went to Europe last year, this year it’s Asia

Helloworld
3:27pm
July 16, 2025
We have updated our forecasts for HLO’s revised FY25 EBITDA guidance. Effectively, a change in business mix has impacted TTV growth, overrides and group margins. While HLO’s release was relatively upbeat about FY26, we are somewhat cautious on the 1H26 as we expect there will still be some impact from macro-economic issues. Despite HLO’s undemanding trading multiples, we maintain a Hold rating until there is a clearer picture on its outlook and earnings growth resumes.

Regulatory outcomes now better known

Tyro Payments
3:27pm
July 16, 2025
The Reserve Bank of Australia (RBA) has released a Consultation Paper as part of its Review of Merchant Card Payment Costs and Surcharging.  With management adamant the regulatory changes won’t impact TYR’s profitability, we think risks from surcharging changes have been overstated. We make no alterations to our earnings or price target in this note. We continue to see TYR as unvalued and with >20% upside to our PT (A$1.55), we maintain our BUY recommendation.

Landing a big one

Wrkr
3:27pm
July 15, 2025
WRK has signed AustralianSuper, the largest Superannuation Fund in Australia, as a customer. This deal, on the back of WRK’s successful recent pilot with REST, gives significant credibility to the WRK Super Fund product. The contract is expected to be operational by the end of FY26, positioning WRK well to see strongly improving profitability in FY27.

Model update

Regal Partners
3:27pm
July 15, 2025
In this note we update our earnings estimates to reflect 1HCY25 performance fees, along with our expectations for a slight moderation in the funds management margin and an increased non-controlling interest charge (vs prior expectations). Trading at a PER of 14x (CY26), with a strong balance sheet and capacity to continue growing FUM, we retain our Add rating with a price target of $3.30/sh.

One polymer to heal them all

Tetratherix
3:27pm
July 14, 2025
Tetratherix (TTX) is a medical device company that has developed a special material which can be used in regenerative medicine and surgery. TetramatrixTM is a fluid-like material that can be injected into the body without triggering a foreign body response. Once in the body, the increase in temperature transforms the liquid into a 3D gel-like matrix that adheres to tissues and can be used in various indications to help bridge injuries or support healing. Initially, TTX will develop products aimed at three franchisees - bone regeneration, tissue spacing, and tissue healing. Management estimates the potential addressable market at US$6.8bn. The funds raised at the IPO will be used to expand the manufacturing facilities and enable short-term milestones to be achieved including collaborations with larger industry players, clinical trial results and regulatory approvals. Achievement of key milestones will drive investor interest. We initiate coverage of TTX with a Speculative Buy rating and a target price of A$5.72.

Sunshine through the clouds

Johns Lyng Group
3:27pm
July 11, 2025
Following JLG’s recent approach from Pacific Equity Partners (PEP), the company has entered into a scheme of implementation to acquire all JLG shares for A$4.00/sh, at an equity value of A$1.1bn, towards the high end of our expectations. We see this as a reasonable offer considering JLG’s recent share price weakness and the near-term earnings softness as the group works through the rebuild of NSW IB&RS BAU volumes. With no changes or update with respect to JLG’s FY25 guidance and the proximity to JLG’s result (expected ~26th August 2025), we make no changes to our current forecast. Our price target, however, moves to align with the scheme offer price of $4.00, and we retain our HOLD rating.

News & Insights

Michael Knox, Chief Economist looks at what might have happened in January 2026 if the cuts in corporate tax rates in Trumps first term were not renewed and extended in the One Big Beautiful Bill

In recent weeks, a number of media commentators have criticized Donald Trump's " One big Beautiful Bill " on the basis of a statement by the Congressional Budget Office that under existing legislation the bill adds $US 3.4 trillion to the US Budget deficit. They tend not to mention that this is because the existing law assumes that all the tax cuts made in 2017 by the first Trump Administration expire at the end of this year.

Let’s us look at what might have happened in January 2026 if the cuts in US corporate tax rates in Trumps first term were not renewed and extended in the One Big Beautiful Bill.

Back in 2016 before the first Trump administration came to office in his first term, the US corporate tax rate was then 35%. In 2017 the Tax Cut and Jobs Act reduced the corporate tax rate to 21%. Because this bill was passed as a "Reconciliation Bill “, This meant it required only a simple majority of Senate votes to pass. This tax rate of 21% was due to expire in January 2026.

The One Big Beautiful Bill has made the expiring tax cuts permanent; this bill was signed into law on 4 July 2025. Now of course the same legislation also made a large number of individual tax cuts in the original 2017 bill permanent.

What would have happened if the bill had not passed. Let us construct what economists call a "Counterfactual"

Let’s just restrict ourselves to the case of what have happened in 2026 if the US corporate tax had risen to the prior rate of 35%.

This is an increase in the corporate tax rate of 14%. This increase would generate a sudden fall in US corporate after-tax earnings in January 2026 of 14%. What effect would that have on the level of the S&P 500?

The Price /Earnings Ratio of the S&P500 in July 2025 was 26.1.

Still the ten-year average Price/ Earnings Ratio for the S&P500 is only 18.99. Let’s say 19 times.

Should earnings per share have suddenly fallen by 14%, then the S&P 500 might have fallen by 14% multiplied by the short-term Price/ Earnings ratio.

This means a likely fall in the S&P500 of 37%.

As the market recovered to long term Price Earnings ratio of 19 this fall might then have ben be reduced to 27%.

Put simply, had the One Big, beautiful Bill not been passed, then in 2026 the US stock market might suddenly have fallen by 37% before then recovering to a fall of 27% .

The devastating effect on the US and indeed World economy might plausibly have caused a major recession.

On 9 June Kevin Hassert the Director of the National Economic Council said in a CBS interview with Margaret Brennan that if the bill did not pass US GDP would fall by 4% and 6-7 million Americans would lose their jobs.

The Passage of the One Big Beautiful Bill on 4 July thus avoided One Big Ugly Disaster.

Read more
On 7 July the AFR published a list of 37 Economists who had answered a poll on when the RBA would next cut rates. 32 of them thought that the RBA would cut on 8 July. Only 5 of them did not believe the RBA would cut, Michael Knox being one of them.

On 7 July the AFR published a list of 37 Economists who had answered a poll on when the RBA would next cut rates. 32 of them thought that the RBA would cut on 8 July. Only 5 of them did not believe the RBA would cut on 8 July. I was one of them. The RBA did not cut.

So today I will talk about how I came to that decision. First, lets look at our model of official interest rates. Back in January 2015 I went to a presentation in San Franciso by Stan Fishcer . Stan was a celebrated economist who at that time was Ben Bernanke's deputy at the Federal Reserve. Stan gave a talk about how the Fed thought about interest rates.

Stan presented a model of R*. This is the real short rate of the Fed Funds Rate at which monetary policy is at equilibrium. Unemployment was shown as a most important variable. So was inflationary expectations.

This then logically lead to a model where the nominal level of the Fed funds rate was driven by Inflation, Inflationary expectations and unemployment. Unemployment was important because of its effect on future inflation. The lower the level of unemployment the higher the level of future inflation and the higher the level of the Fed funds rate. I tried the model and it worked. It worked not just for the Fed funds rate. It also worked in Australia for Australian cash rate.

Recently though I have found that while the model has continued to work to work for the Fed funds rate It has been not quite as good in modelling that Australian Cash Rate. I found the answer to this in a model of Australian inflation published by the RBA. The model showed Australian Inflation was not just caused by low unemployment, It was also caused by high import price rises. Import price inflation was more important in Australia because imports were a higher level of Australian GDP than was the case in the US.

This was important in Australia than in the US because Australian import price inflation was close to zero for the 2 years up to the end of 2024. Import prices rose sharply in the first quarter of 2025. What would happen in the second quarter of 2025 and how would it effect inflation I could not tell. The only thing I could do is wait for the Q2 inflation numbers to come out for Australia.

I thought that for this reason and other reasons the RBA would also wait for the Q2 inflation numbers to come out. There were other reasons as well. The Quarterly CPI was a more reliable measure of the CPI and was a better measure of services inflation than the monthly CPI. The result was that RBA did not move and voiced a preference for quarterly measure of inflation over monthly version.

Lets look again at R* or the real level of the Cash rate for Australia .When we look at the average real Cash rate since January 2000 we find an average number of 0.85%. At an inflation target of 2.5 % this suggests this suggest an equilibrium Cash rate of 3.35%

Model of the Australian Cash Rate.
Model of the Australian Cash Rate


What will happen next? We think that the after the RBA meeting of 11 and 12 August the RBA will cut the Cash rate to 3.6%

We think that after the RBA meeting of 8 and 9 December the RBA will cut the Cash rate to 3.35%

Unless Quarterly inflation falls below 2.5% , the Cash rate will remain at 3.35% .

Read more
Investment Watch is a quarterly publication for insights in equity and economic strategy. Recent months have been marked by sharp swings in market sentiment, driven by shifting global trade dynamics, geopolitical tensions, and policy uncertainty.

Investment Watch is a quarterly publication produced by Morgans that delves into key insights for equity and economic strategy.

This publication covers

Economics - 'The challenge of Australian productivity' and 'Iran, from the Suez blockade to the 12 day war'
Asset Allocation
- 'Prioritise portfolio resilience amidst the prevailing uncertainty'
Equity Strategy
- 'Rethinking sector preferences and portfolio balance'
Fixed Interest
- 'Market volatility analysis: Low beta investment opportunities'
Banks
- 'Outperformance driving the broader market index'
Industrials
- 'New opportunities will arise'
Resources and Energy
- 'Getting paid to wait in the majors'
Technology
- 'Buy the dips'
Consumer discretionary
- 'Support remains in place'
Telco
- 'A cautious eye on competitive intensity'
Travel
- 'Demand trends still solid'
Property
- 'An improving Cycle'

Recent months have been marked by sharp swings in market sentiment, driven by shifting global trade dynamics, geopolitical tensions, and policy uncertainty. The rapid pace of US policy announcements, coupled with reversals, has made it difficult for investors to form strong convictions or accurately assess the impact on growth and earnings. While trade tariffs are still a concern, recent progress in US bilateral negotiations and signs of greater policy stability have reduced immediate headline risks.

We expect that more stable policies, potential tax cuts, and continued innovation - particularly in AI - will support a gradual pickup in investment activity. In this environment, we recommend prioritising portfolio resilience. This means maintaining diversification, focusing on quality, and being prepared to adjust exposures as new risks or opportunities emerge. This quarter, we update our outlook for interest rates and also explore the implications of the conflict in the Middle East on portfolios. As usual, we provide an outlook for the key sectors of the Australian market and where we see the best tactical opportunities.


Morgans clients receive exclusive insights such as access to our latest Investment Watch publication. Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more